The move forms part of C.tech’s $600,000 expansion as it ramps up the development of its next-generation device aimed at making pacemaker surgery more accurate.
The move forms part of C.tech’s $600,000 expansion as it ramps up the development of its next-generation device aimed at making pacemaker surgery more accurate.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.